Home > > Global Liver Disease Diagnostics Market Report
TABLE OF CONTENTS CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 3.1. OVERVIEW 3.2. IMAGING 3.2.1. IMAGING MARKET, BY REGION 3.2.1.1. NORTH AMERICA IMAGING MARKET, BY COUNTRY 3.2.1.2. EUROPE IMAGING MARKET, BY COUNTRY 3.2.1.3. ASIA IMAGING MARKET, BY COUNTRY 3.2.1.4. MIDDLE EAST & AFRICA IMAGING MARKET, BY COUNTRY 3.3. LABORATORY TESTS 3.3.1. LABORATORY TESTS MARKET, BY REGION 3.3.1.1. NORTH AMERICA LABORATORY TESTS MARKET, BY COUNTRY 3.3.1.2. EUROPE LABORATORY TESTS MARKET, BY COUNTRY 3.3.1.3. ASIA LABORATORY TESTS MARKET, BY COUNTRY 3.3.1.4. MIDDLE EAST & AFRICA LABORATORY TESTS MARKET, BY COUNTRY 3.4. ENDOSCOPY 3.4.1. ENDOSCOPY MARKET, BY REGION 3.4.1.1. NORTH AMERICA ENDOSCOPY MARKET, BY COUNTRY 3.4.1.2. EUROPE ENDOSCOPY MARKET, BY COUNTRY 3.4.1.3. ASIA ENDOSCOPY MARKET, BY COUNTRY 3.4.1.4. MIDDLE EAST & AFRICA ENDOSCOPY MARKET, BY COUNTRY 3.5. BIOPSY 3.5.1. BIOPSY MARKET, BY REGION 3.5.1.1. NORTH AMERICA BIOPSY MARKET, BY COUNTRY 3.5.1.2. EUROPE BIOPSY MARKET, BY COUNTRY 3.5.1.3. ASIA BIOPSY MARKET, BY COUNTRY 3.5.1.4. MIDDLE EAST & AFRICA BIOPSY MARKET, BY COUNTRY 3.6. OTHER DIAGNOSIS TECHNIQUES 3.6.1. OTHER DIAGNOSIS TECHNIQUES MARKET, BY REGION 3.6.1.1. NORTH AMERICA OTHER DIAGNOSIS TECHNIQUES MARKET, BY COUNTRY 3.6.1.2. EUROPE OTHER DIAGNOSIS TECHNIQUES MARKET, BY COUNTRY 3.6.1.3. ASIA OTHER DIAGNOSIS TECHNIQUES MARKET, BY COUNTRY 3.6.1.4. MIDDLE EAST & AFRICA OTHER DIAGNOSIS TECHNIQUES MARKET, BY COUNTRY CHAPTER 4: GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 4.1. OVERVIEW 4.2. HOSPITALS 4.2.1. HOSPITALS MARKET, BY REGION 4.2.1.1. NORTH AMERICA HOSPITALS MARKET, BY COUNTRY 4.2.1.2. EUROPE HOSPITALS MARKET, BY COUNTRY 4.2.1.3. ASIA HOSPITALS MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA HOSPITALS MARKET, BY COUNTRY 4.3. LABORATORIES 4.3.1. LABORATORIES MARKET, BY REGION 4.3.1.1. NORTH AMERICA LABORATORIES MARKET, BY COUNTRY 4.3.1.2. EUROPE LABORATORIES MARKET, BY COUNTRY 4.3.1.3. ASIA LABORATORIES MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA LABORATORIES MARKET, BY COUNTRY 4.4. OTHER END USES 4.4.1. OTHER END USES MARKET, BY REGION 4.4.1.1. NORTH AMERICA OTHER END USES MARKET, BY COUNTRY 4.4.1.2. EUROPE OTHER END USES MARKET, BY COUNTRY 4.4.1.3. ASIA OTHER END USES MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA OTHER END USES MARKET, BY COUNTRY CHAPTER 5: GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY REGION 5.1. OVERVIEW 5.2. NORTH AMERICA 5.2.1. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.2.2. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.2.3. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, BY COUNTRY 5.2.3.1. U.S. 5.2.3.1.1. U.S. LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.2.3.1.2. U.S. LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.2.3.2. CANADA 5.2.3.2.1. CANADA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.2.3.2.2. CANADA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.3. EUROPE 5.3.1. EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.3.2. EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.3.3. EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY COUNTRY 5.3.3.1. GERMANY 5.3.3.1.1. GERMANY LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.3.3.1.2. GERMANY LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.3.3.2. U.K. 5.3.3.2.1. U.K. LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.3.3.2.2. U.K. LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.3.3.3. FRANCE 5.3.3.3.1. FRANCE LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.3.3.3.2. FRANCE LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.3.3.4. ITALY 5.3.3.4.1. ITALY LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.3.3.4.2. ITALY LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.3.3.5. SPAIN 5.3.3.5.1. SPAIN LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.3.3.5.2. SPAIN LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.3.3.6. REST OF EUROPE 5.3.3.6.1. REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.3.3.6.2. REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.4. ASIA 5.4.1. ASIA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.4.2. ASIA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.4.3. ASIA LIVER DISEASE DIAGNOSTICS MARKET, BY COUNTRY 5.4.3.1. CHINA 5.4.3.1.1. CHINA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.4.3.1.2. CHINA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.4.3.2. JAPAN 5.4.3.2.1. JAPAN LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.4.3.2.2. JAPAN LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.4.3.3. SOUTH KOREA 5.4.3.3.1. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.4.3.3.2. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.4.3.4. INDIA 5.4.3.4.1. INDIA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.4.3.4.2. INDIA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.4.3.5. INDONESIA 5.4.3.5.1. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.4.3.5.2. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.4.3.6. REST OF ASIA 5.4.3.6.1. REST OF ASIA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.4.3.6.2. REST OF ASIA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.5. MIDDLE EAST & AFRICA 5.5.1. MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.5.2. MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.5.3. MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET, BY COUNTRY 5.5.3.1. BRAZIL 5.5.3.1.1. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.5.3.1.2. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.5.3.2. MEXICO 5.5.3.2.1. MEXICO LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.5.3.2.2. MEXICO LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.5.3.3. SOUTH AFRICA 5.5.3.3.1. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.5.3.3.2. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.5.3.4. AUSTRALIA 5.5.3.4.1. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.5.3.4.2. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.5.3.5. REST OF MENA 5.5.3.5.1. REST OF MENA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.5.3.5.2. REST OF MENA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE TABLE 96. REST OF MENA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION)LIST OF TABLES TABLE 01. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 02. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 03. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 04. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 05. IMAGING MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 06. NORTH AMERICA IMAGING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 07. EUROPE IMAGING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 08. ASIA IMAGING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 09. MIDDLE EAST & AFRICA IMAGING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. LABORATORY TESTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 11. NORTH AMERICA LABORATORY TESTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 12. EUROPE LABORATORY TESTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 13. ASIA LABORATORY TESTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 14. MIDDLE EAST & AFRICA LABORATORY TESTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 15. ENDOSCOPY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 16. NORTH AMERICA ENDOSCOPY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 17. EUROPE ENDOSCOPY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 18. ASIA ENDOSCOPY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 19. MIDDLE EAST & AFRICA ENDOSCOPY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 20. BIOPSY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 21. NORTH AMERICA BIOPSY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 22. EUROPE BIOPSY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 23. ASIA BIOPSY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 24. MIDDLE EAST & AFRICA BIOPSY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. OTHER DIAGNOSIS TECHNIQUES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 26. NORTH AMERICA OTHER DIAGNOSIS TECHNIQUES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 27. EUROPE OTHER DIAGNOSIS TECHNIQUES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 28. ASIA OTHER DIAGNOSIS TECHNIQUES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. MIDDLE EAST & AFRICA OTHER DIAGNOSIS TECHNIQUES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 31. HOSPITALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 32. NORTH AMERICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 33. EUROPE HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. ASIA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. MIDDLE EAST & AFRICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. LABORATORIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 37. NORTH AMERICA LABORATORIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. EUROPE LABORATORIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. ASIA LABORATORIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. MIDDLE EAST & AFRICA LABORATORIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. OTHER END USES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 42. NORTH AMERICA OTHER END USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. EUROPE OTHER END USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. ASIA OTHER END USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. MIDDLE EAST & AFRICA OTHER END USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 47. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($MILLION) TABLE 48. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 49. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. U.S. LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 51. U.S. LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 52. CANADA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 53. CANADA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 54. EUROPE LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($MILLION) TABLE 55. EUROPE LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 56. EUROPE LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 57. GERMANY LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 58. GERMANY LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 59. U.K. LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 60. U.K. LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 61. FRANCE LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 62. FRANCE LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 63. ITALY LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 64. ITALY LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 65. SPAIN LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 66. SPAIN LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 67. REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 68. REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 69. ASIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($MILLION) TABLE 70. ASIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 71. ASIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 72. CHINA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 73. CHINA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 74. JAPAN LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 75. JAPAN LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 76. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 77. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 78. INDIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 79. INDIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 80. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 81. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 82. REST OF ASIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 83. REST OF ASIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 84. MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($MILLION) TABLE 85. MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 86. MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 87. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 88. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 89. MEXICO LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 90. MEXICO LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 91. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 92. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 93. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 94. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 95. REST OF MENA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 96. REST OF MENA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION)LIST OF FIGURES CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 3.1. OVERVIEW 3.2. IMAGING 3.2.1. IMAGING MARKET, BY REGION 3.2.1.1. NORTH AMERICA IMAGING MARKET, BY COUNTRY 3.2.1.2. EUROPE IMAGING MARKET, BY COUNTRY 3.2.1.3. ASIA IMAGING MARKET, BY COUNTRY 3.2.1.4. MIDDLE EAST & AFRICA IMAGING MARKET, BY COUNTRY 3.3. LABORATORY TESTS 3.3.1. LABORATORY TESTS MARKET, BY REGION 3.3.1.1. NORTH AMERICA LABORATORY TESTS MARKET, BY COUNTRY 3.3.1.2. EUROPE LABORATORY TESTS MARKET, BY COUNTRY 3.3.1.3. ASIA LABORATORY TESTS MARKET, BY COUNTRY 3.3.1.4. MIDDLE EAST & AFRICA LABORATORY TESTS MARKET, BY COUNTRY 3.4. ENDOSCOPY 3.4.1. ENDOSCOPY MARKET, BY REGION 3.4.1.1. NORTH AMERICA ENDOSCOPY MARKET, BY COUNTRY 3.4.1.2. EUROPE ENDOSCOPY MARKET, BY COUNTRY 3.4.1.3. ASIA ENDOSCOPY MARKET, BY COUNTRY 3.4.1.4. MIDDLE EAST & AFRICA ENDOSCOPY MARKET, BY COUNTRY 3.5. BIOPSY 3.5.1. BIOPSY MARKET, BY REGION 3.5.1.1. NORTH AMERICA BIOPSY MARKET, BY COUNTRY 3.5.1.2. EUROPE BIOPSY MARKET, BY COUNTRY 3.5.1.3. ASIA BIOPSY MARKET, BY COUNTRY 3.5.1.4. MIDDLE EAST & AFRICA BIOPSY MARKET, BY COUNTRY 3.6. OTHER DIAGNOSIS TECHNIQUES 3.6.1. OTHER DIAGNOSIS TECHNIQUES MARKET, BY REGION 3.6.1.1. NORTH AMERICA OTHER DIAGNOSIS TECHNIQUES MARKET, BY COUNTRY 3.6.1.2. EUROPE OTHER DIAGNOSIS TECHNIQUES MARKET, BY COUNTRY 3.6.1.3. ASIA OTHER DIAGNOSIS TECHNIQUES MARKET, BY COUNTRY 3.6.1.4. MIDDLE EAST & AFRICA OTHER DIAGNOSIS TECHNIQUES MARKET, BY COUNTRY CHAPTER 4: GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 4.1. OVERVIEW 4.2. HOSPITALS 4.2.1. HOSPITALS MARKET, BY REGION 4.2.1.1. NORTH AMERICA HOSPITALS MARKET, BY COUNTRY 4.2.1.2. EUROPE HOSPITALS MARKET, BY COUNTRY 4.2.1.3. ASIA HOSPITALS MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA HOSPITALS MARKET, BY COUNTRY 4.3. LABORATORIES 4.3.1. LABORATORIES MARKET, BY REGION 4.3.1.1. NORTH AMERICA LABORATORIES MARKET, BY COUNTRY 4.3.1.2. EUROPE LABORATORIES MARKET, BY COUNTRY 4.3.1.3. ASIA LABORATORIES MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA LABORATORIES MARKET, BY COUNTRY 4.4. OTHER END USES 4.4.1. OTHER END USES MARKET, BY REGION 4.4.1.1. NORTH AMERICA OTHER END USES MARKET, BY COUNTRY 4.4.1.2. EUROPE OTHER END USES MARKET, BY COUNTRY 4.4.1.3. ASIA OTHER END USES MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA OTHER END USES MARKET, BY COUNTRY CHAPTER 5: GLOBAL LIVER DISEASE DIAGNOSTICS MARKET, BY REGION 5.1. OVERVIEW 5.2. NORTH AMERICA 5.2.1. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.2.2. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.2.3. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET, BY COUNTRY 5.2.3.1. U.S. 5.2.3.1.1. U.S. LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.2.3.1.2. U.S. LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.2.3.2. CANADA 5.2.3.2.1. CANADA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.2.3.2.2. CANADA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.3. EUROPE 5.3.1. EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.3.2. EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.3.3. EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY COUNTRY 5.3.3.1. GERMANY 5.3.3.1.1. GERMANY LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.3.3.1.2. GERMANY LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.3.3.2. U.K. 5.3.3.2.1. U.K. LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.3.3.2.2. U.K. LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.3.3.3. FRANCE 5.3.3.3.1. FRANCE LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.3.3.3.2. FRANCE LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.3.3.4. ITALY 5.3.3.4.1. ITALY LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.3.3.4.2. ITALY LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.3.3.5. SPAIN 5.3.3.5.1. SPAIN LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.3.3.5.2. SPAIN LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.3.3.6. REST OF EUROPE 5.3.3.6.1. REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.3.3.6.2. REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.4. ASIA 5.4.1. ASIA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.4.2. ASIA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.4.3. ASIA LIVER DISEASE DIAGNOSTICS MARKET, BY COUNTRY 5.4.3.1. CHINA 5.4.3.1.1. CHINA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.4.3.1.2. CHINA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.4.3.2. JAPAN 5.4.3.2.1. JAPAN LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.4.3.2.2. JAPAN LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.4.3.3. SOUTH KOREA 5.4.3.3.1. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.4.3.3.2. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.4.3.4. INDIA 5.4.3.4.1. INDIA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.4.3.4.2. INDIA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.4.3.5. INDONESIA 5.4.3.5.1. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.4.3.5.2. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.4.3.6. REST OF ASIA 5.4.3.6.1. REST OF ASIA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.4.3.6.2. REST OF ASIA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.5. MIDDLE EAST & AFRICA 5.5.1. MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.5.2. MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.5.3. MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET, BY COUNTRY 5.5.3.1. BRAZIL 5.5.3.1.1. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.5.3.1.2. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.5.3.2. MEXICO 5.5.3.2.1. MEXICO LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.5.3.2.2. MEXICO LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.5.3.3. SOUTH AFRICA 5.5.3.3.1. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.5.3.3.2. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.5.3.4. AUSTRALIA 5.5.3.4.1. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.5.3.4.2. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE 5.5.3.5. REST OF MENA 5.5.3.5.1. REST OF MENA LIVER DISEASE DIAGNOSTICS MARKET, BY DIAGNOSIS TECHNIQUE 5.5.3.5.2. REST OF MENA LIVER DISEASE DIAGNOSTICS MARKET, BY END-USE TABLE 01. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 02. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 03. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 04. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 05. IMAGING MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 06. NORTH AMERICA IMAGING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 07. EUROPE IMAGING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 08. ASIA IMAGING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 09. MIDDLE EAST & AFRICA IMAGING MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. LABORATORY TESTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 11. NORTH AMERICA LABORATORY TESTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 12. EUROPE LABORATORY TESTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 13. ASIA LABORATORY TESTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 14. MIDDLE EAST & AFRICA LABORATORY TESTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 15. ENDOSCOPY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 16. NORTH AMERICA ENDOSCOPY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 17. EUROPE ENDOSCOPY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 18. ASIA ENDOSCOPY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 19. MIDDLE EAST & AFRICA ENDOSCOPY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 20. BIOPSY MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 21. NORTH AMERICA BIOPSY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 22. EUROPE BIOPSY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 23. ASIA BIOPSY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 24. MIDDLE EAST & AFRICA BIOPSY MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 25. OTHER DIAGNOSIS TECHNIQUES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 26. NORTH AMERICA OTHER DIAGNOSIS TECHNIQUES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 27. EUROPE OTHER DIAGNOSIS TECHNIQUES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 28. ASIA OTHER DIAGNOSIS TECHNIQUES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 29. MIDDLE EAST & AFRICA OTHER DIAGNOSIS TECHNIQUES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 30. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 31. HOSPITALS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 32. NORTH AMERICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 33. EUROPE HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. ASIA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 35. MIDDLE EAST & AFRICA HOSPITALS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. LABORATORIES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 37. NORTH AMERICA LABORATORIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. EUROPE LABORATORIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. ASIA LABORATORIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 40. MIDDLE EAST & AFRICA LABORATORIES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. OTHER END USES MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 42. NORTH AMERICA OTHER END USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. EUROPE OTHER END USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. ASIA OTHER END USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 45. MIDDLE EAST & AFRICA OTHER END USES MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. GLOBAL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 47. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($MILLION) TABLE 48. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 49. NORTH AMERICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 50. U.S. LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 51. U.S. LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 52. CANADA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 53. CANADA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 54. EUROPE LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($MILLION) TABLE 55. EUROPE LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 56. EUROPE LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 57. GERMANY LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 58. GERMANY LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 59. U.K. LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 60. U.K. LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 61. FRANCE LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 62. FRANCE LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 63. ITALY LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 64. ITALY LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 65. SPAIN LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 66. SPAIN LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 67. REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 68. REST OF EUROPE LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 69. ASIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($MILLION) TABLE 70. ASIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 71. ASIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 72. CHINA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 73. CHINA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 74. JAPAN LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 75. JAPAN LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 76. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 77. SOUTH KOREA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 78. INDIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 79. INDIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 80. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 81. INDONESIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 82. REST OF ASIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 83. REST OF ASIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 84. MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($MILLION) TABLE 85. MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($MILLION) TABLE 86. MIDDLE EAST & AFRICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 87. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 88. BRAZIL LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 89. MEXICO LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 90. MEXICO LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 91. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 92. SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 93. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 94. AUSTRALIA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION) TABLE 95. REST OF MENA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY DIAGNOSIS TECHNIQUE, 2023-2030, ($ MILLION) TABLE 96. REST OF MENA LIVER DISEASE DIAGNOSTICS MARKET VALUE, BY END-USE, 2023-2030, ($ MILLION)